Colgate-Palmolive Company $CL Shares Sold by State Street Corp

State Street Corp lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,474,785 shares of the company’s stock after selling 208,473 shares during the period. State Street Corp owned approximately 6.01% of Colgate-Palmolive worth $3,830,478,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC boosted its position in Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares in the last quarter. Triumph Capital Management boosted its position in Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after purchasing an additional 127 shares in the last quarter. Jessup Wealth Management Inc purchased a new stake in Colgate-Palmolive during the fourth quarter worth $26,000. Maseco LLP purchased a new stake in Colgate-Palmolive during the fourth quarter worth $27,000. Finally, Global Wealth Strategies & Associates boosted its position in Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.0%

Shares of NYSE:CL opened at $89.40 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock’s fifty day simple moving average is $86.85 and its 200-day simple moving average is $86.25. The company has a market capitalization of $71.54 billion, a P/E ratio of 34.79, a P/E/G ratio of 4.71 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the prior year, the business earned $0.91 earnings per share. The business’s revenue was up 8.4% on a year-over-year basis. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Royal Bank Of Canada reiterated an “outperform” rating and set a $102.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Piper Sandler decreased their target price on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. TD Cowen reiterated a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.